Basic Information
| LncRNA/CircRNA Name | AL391421.1-3:1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | Microarray, qPCR |
| Sample | hepatocellular carcinoma serum samples |
| Expression Pattern | down-regulated |
| Function Description | The data showed that the expression level of the lncRNA lnc-AL391421.1-3:1 was downregulated, while the lncRNAs lnc-POLL-6:1andlnc-CYB5R3-1:2 as well as the mRNAs UBXN11, DDX28 and WDR91 were upregulated in the serum samples from HCC LNM patients. |
| Pubmed ID | 29981417 |
| Year | 2018 |
| Title | Integrated Analysis of Long Noncoding RNA Expression Profiles in Lymph Node Metastasis of Hepatocellular Carcinoma |
External Links
| Links for AL391421.1-3:1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |